1. 1. Feshchenko Yu.I., Cheren'ko S.O., Byalyk Y.B. et al. Efektyvnist' statsionarnoho likuvannya khvorykh na khimiorezystentnyy tuberkul'oz na moment zavershennya intensyvnoyi fazy khimioterapiyi [Efficacy of initial phase of chemotherapy in-patiens with the drug resistant tuberculosis]. Ukr. khimioterapevtych. zhurn. 2010;2:33-7. (Ua).
2. 2. Cherenko S.O., Litvinenko N.A, BarbovaІ A.I. et al. Chastota ta profil' medykamentoznoyi rezystentnosti MBT u khvorykh na mul'tyrezystentnyy tuberkul'oz i tuberkul'oz iz rozshyrenoyu rezystentnistyu zalezhno vid vypadku zakhvoryuvannya, kharakteru ta tryvalosti poperedn'oho likuvannya [The frequency and profile of drug resistance of MBT in patients with multidrug-resistant tuberculosis and tuberculosis with expanded resistance depending on the case of the disease, the nature and duration of the preliminary treatment]. Tuberculosis, Lung Diseases, HIV Infection. 2013;2(13):19-25.(Ua).
3. 3. Feshchenko Yu.I., Mel'nyk V.M., Turchenko L.V. et al. Kontseptsiya reformuvannya protytuberkul'oznoyi sluzhby ta optymizatsiya protytuberkul'oznykh zakhodiv v Ukrayini (proyekt) [A concept of reformation of tuberculosis healthcare system and optimization of anti-tuberculosis activity in ukraine (project)]. Ukr. Pulmonol. J. 2015;1:5-9. (Ua).
4. 4. Lepshina S.M. Problemy khimiorezistentnogo tuberkuloza na sovremennom etape [Problems of chemoresistant tuberculosis at the present stage].Archives of clinical and experimental medicine. 2008;1:77-80. (Ru).
5. 5. Lumb R., Bastian I.B., Jelfs P.J. et. al. Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011: A report of the Australian Mycobacterium Reference Laboratory Network. Comm. Dis. Intelligence Quarterly Rep. 2014;38(4):369-75.